Skip to content

Medical-device intelligence

QLT: Covid-19 Multi-Analyte Respiratory Panel Nucleic Acid Devices

FDA product code QLT: Covid-19 Multi-Analyte Respiratory Panel Nucleic Acid Devices. View classification details, related manufacturers, 510(k) clearances, and recall records.

FDA classification ↗

Classification details

Product code
QLT
FDA device name
Covid-19 Multi-Analyte Respiratory Panel Nucleic Acid Devices
Device class
N
Regulation number
Not provided
Medical specialty
Unknown
Review panel
MI

FDA definition

Multi-analyte nucleic acid-based in vitro diagnostic devices for the simultaneous qualitative detection and differentiation of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), that causes COVID-19, and common respiratory microorganisms in human respiratory and/or acceptable clinical specimens collected from individuals suspected of respiratory viral infection consistent with COVID-19 by a healthcare provider. Results should not be used as the sole basis for diagnosis, treatment or other patient management decisions and must be combined with clinical observations, patient history, and/or epidemiological information.
Explore unknown records →
A product code groups records by FDA classification. It does not establish identical intended uses, commercial availability, or comparative device safety.

Record activity in this scope

0 clearance records and 11 recall records in the covered releases, across 5 source company names and 1 product codes. Dated history runs from Jul 15, 2020 to Sep 5, 2024.

Monthly counts through October 2026
Month510(k) decisionsRecall initiations
October 202500
November 202500
December 202500
January 202600
February 202600
March 202600
April 202600
May 202600
June 202600
July 202600
August 202600
September 202600
October 202600

Product codes represented

All-history totals use the covered releases; monthly counts stop at the last calendar month covered by both sources. Clearances use decision dates; recalls use initiation dates. 0 records lack the required date and are excluded from monthly counts. These are records, not product launches, market share, incidence rates, or comparative safety. Feed filters below do not change this overview.

Clearances and recall records

11 matching records
Device / recordCompany in FDA recordSourceSource date
NxTAG Respiratory Pathogen Panel +SARS-CoV-2, REF: I056C0468Z-0043-2025 · QLTLuminex Molecular Diagnostics IncRecallOct 9, 2024FDA classification date
QIAstat-Dx Respiratory SARS-CoV-2 Panel -US IVD qualitative test intended for analyzing nasopharyngeal swab (NPS) samples from patients suspected…Z-2245-2023 · QLTQiagen GmbHRecallJul 27, 2023FDA classification date
QIAstat-Dx Respiratory SARS-CoV-2 Panel (V1 and V2, CE IVD, not US IVD, not sold in the US.) Qualitative test intended for analyzing nasopharyn…Z-2246-2023 · QLTQiagen GmbHRecallJul 27, 2023FDA classification date
QIAstat-Dx Respiratory SARS-CoV-2 Panel multiplexed nucleic acid real-time PCR test, Reference Number 691223Z-1683-2023 · QLTQiagen Sciences LLCRecallJun 2, 2023FDA classification date
cobas SARS-CoV-2 & Influenza A/B Qualitative assay for use on the cobas 6800/8800 Systems; Material number 09233474190Z-1104-2023 · QLTRoche Molecular Systems, Inc.RecallFeb 7, 2023FDA classification date
cobas SARS-CoV-2 & Influenza A/B Qualitative nucleic acid test for use on the cobas 5800/6800/8800 Systems; Material Number 09446125190Z-1105-2023 · QLTRoche Molecular Systems, Inc.RecallFeb 7, 2023FDA classification date
cobas Influenza A/B & RSV UC (Utility Channel) Qualitative nucleic acid test for use on the cobas 6800/8800 Systems; Material number 09233962190Z-1106-2023 · QLTRoche Molecular Systems, Inc.RecallFeb 7, 2023FDA classification date
NeuMoDx Flu A-B/RSV/SARS-CoV-2 Vantage Test Strip, Model No. 300900Z-1251-2022 · QLTNeuMoDx Molecular IncRecallJun 8, 2022FDA record creation date
QIAstat-Dx Respiratory SARS-CoV-2 Panel (US IVD under FDA EUA 200075); REF 691223Z-0455-2022 · QLTQiagen Sciences LLCRecallJan 5, 2022FDA record creation date
cobas SARS-CoV-2 & Influenza A/B Test for use on the cobas Liat System, Catalog Number 09211101190Z-2498-2021 · QLTRoche Molecular Systems, Inc.RecallSep 21, 2021FDA record creation date
QIAstat-Dx Respiratory SARS-CoV-2 Panel REF 691223 (US IVD under FDA EUA) - Product Usage: intended for the qualitative detection and differentia…Z-2938-2020 · QLTQiagen Sciences LLCRecallSep 4, 2020FDA record creation date

Manufacturers in these records

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 21, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 21, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 21, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗